Oxybuprocaine hydrochloride

Benoxinate Hydrochloride is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982. Its therapeutic use is listed as anesthetics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Benoxinate hydrochloride, Cebesine, Conjuncain, Lacrimin and Novesina. Its PubChem CID is 6420040.

CAS No 5987-82-6
Molecular Formula C17H29ClN2O3
Molecular Weight 344.9 g/mol
Synonyms 2-(diethylamino)ethyl 4-amino-3-butoxybenzoate;hydrochloride

Frequently Asked Questions